Nowadays, the data on the topography, composition and functions of immunocompetent cells in the epidermis, as well as in the covering stratified epithelial lining of the conjunctiva and oral cavity have not been systematized. The interaction of these cells in the stratified (covering) epithelium during damage, trauma and injury remain poorly understood at immunohistochemical and electron microscopic manifestations. To clarify the role of the noted cells in the pathogenesis and sanogenesis in damage and injuries of skin, mucosal layer of conjunctiva and oral cavity it is advisable to study comprehensively corresponding samples of these epithelia in humans and in experiments on small laboratory animals with an emphasis on the expression of MIF and its receptor CD74.
Дранник Г.Н. Современные представления о механизмах врожденного и приобретенного иммунитета и их взаимодействие (часть 1). Журнал «Лiki Украiни» (Киев), 2013, №4,170, с.22-30.
Matejuk A. Skin Immunity. Archivum immunologiae et therapiae experimentalis, 2018, vol. 66, issue 1, pp. 45-54.
doi:10.1007/s00005-017-0477-3.
Nguyen A.V., Soulika A.M. The Dynamics of the Skin's Immune System. Int. J. Mol. Sci., 2019, vol. 20(8), p.1811. doi: 10.3390/ijms20081811.
Mudhar H.S. Update on conjunctival pathology. Indian Journal of Ophthalmology, 2017, vol. 65, issue 9, pp. 797-807. doi: 10.4103/ijo.IJO_364_16.
Lever's Histopathology of the Skin 10th Edition ISBN-13: 978-0781773638.
Быков В.Л. Гистология и эмбриональное развитие органов полости рта человека. В.Л. Быков – Москва: ГЭОТАР-Медиа, 2014, 624 с.
Yan X., Orentas R.J., Johnson B.D. Tumor-derived macrophage migration inhibitory factor (MIF) inhibits T lymphocyte activation. Cytokine, 2006, vol. 33(4), pp. 188-198. doi:10.1016/j.cyto.2006.01.006.
Fan H., Kao W., Yang Y.H. et al. Macrophage migration inhibitory factor inhibits the antiinflammatory effects of glucocorticoids via glucocorticoid-induced leucine zipper. Arthritis Rheumatol., 2014, vol. 66(8), pp. 2059-2070.
doi: 10.1002/art.38689.
Xu L., Li Y., Sun H. et al. Current developments of macrophage migration inhibitory factor (MIF) inhibitors. Drug Discov Today, 2013, vol. 18(11-12), pp. 592-600. doi: 10.1016/j.drudis.2012.12.013.
DiCosmo-Ponticello C.J., Hoover D., Coffman F.D. et al. MIF inhibits monocytic movement through a non-canonical receptor and disruption of temporal Rho GTPase activities in U-937 cells. Cytokine, 2014, vol. 69(1), pp.:47-55. doi: 10.1016/j.cyto.2014.05.005.
Farr L., Ghosh S., Moonah S. Role of MIF Cytokine/CD74 Receptor Pathway in Protecting Against Injury and Promoting Repair. Front Immunol., 2020, vol. 23;11, pp.1273. doi: 10.3389/fimmu.2020.01273.
Takahashi K., Koga K., Linge H.M. et al. Macrophage CD74 contributes to MIF-induced pulmonary inflammation. Respir Res., 2009, vol. 10(1), p. 33. doi: 10.1186/1465-9921-10-33.
Nishihira J. Macrophage migration inhibitory factor (MIF): its essential role in the immune system and cell growth. J. Interferon. Cytokine Res., 2000, vol. 20(9), pp.751-762.
doi: 10.1089/10799900050151012.
Shimizu T. Role of macrophage migration inhibitory factor (MIF) in the skin. J. Dermatol. Sci., 2005, vol.37(2), pp. 65-73. doi: 10.1016/j.jdermsci.2004.08.007.
Halliday G.M., Damian D.L., Rana S., Byrne S.N. The suppressive effects of ultraviolet radiation on immunity in the skin and internal organs: implications for autoimmunity. J. Dermatol. Sci., 2012 vol. 66 (3), pp. 176-182.
doi: 10.1016/j.jdermsci.2011.12.009.
Gilliver S.C., Emmerson E., Bernhagen J., Hardman M.J. MIF: a key player in cutaneous biology and wound healing. Exp. Dermatol., 2011, vol.20, issue 1, pp.1-6.
doi: 10.1111/j.1600-0625.2010.01194.x.